JP2024540220A5 - - Google Patents
Info
- Publication number
- JP2024540220A5 JP2024540220A5 JP2024525855A JP2024525855A JP2024540220A5 JP 2024540220 A5 JP2024540220 A5 JP 2024540220A5 JP 2024525855 A JP2024525855 A JP 2024525855A JP 2024525855 A JP2024525855 A JP 2024525855A JP 2024540220 A5 JP2024540220 A5 JP 2024540220A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- fusion polypeptide
- dsg2
- pharmaceutical composition
- region
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163274707P | 2021-11-02 | 2021-11-02 | |
| US63/274,707 | 2021-11-02 | ||
| PCT/US2022/079106 WO2023081674A1 (en) | 2021-11-02 | 2022-11-02 | Dsg2 compositions and methods |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024540220A JP2024540220A (ja) | 2024-10-31 |
| JP2024540220A5 true JP2024540220A5 (enExample) | 2025-11-11 |
Family
ID=84569745
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024525855A Pending JP2024540220A (ja) | 2021-11-02 | 2022-11-02 | Ｄｓｇ２組成物及び方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240279304A1 (enExample) |
| EP (1) | EP4426430A1 (enExample) |
| JP (1) | JP2024540220A (enExample) |
| KR (1) | KR20240110819A (enExample) |
| CN (1) | CN118369351A (enExample) |
| AR (1) | AR127555A1 (enExample) |
| AU (1) | AU2022382972A1 (enExample) |
| CA (1) | CA3236070A1 (enExample) |
| IL (1) | IL312219A (enExample) |
| MX (1) | MX2024005327A (enExample) |
| TW (1) | TW202334190A (enExample) |
| WO (1) | WO2023081674A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117860721A (zh) * | 2023-12-25 | 2024-04-12 | 五邑大学 | 三甲基氯化铵在制备冠状病毒刺突蛋白受体结合结构域的特异性结合剂中的应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4965197A (en) | 1987-06-12 | 1990-10-23 | Massachusetts Institute Of Technology | Coryneform expression and secretion system |
| KR100316347B1 (ko) | 1998-09-15 | 2002-08-27 | 한미약품(주) | 대장균엔테로톡신ⅱ신호펩티드의변형체와인체성장호르몬의융합단백질을발현하는재조합미생물및그를이용한인체성장호르몬의제조방법 |
| DE10057397A1 (de) | 2000-11-18 | 2002-05-23 | Hella Kg Hueck & Co | Vorrichtung zur Ölstandsmessung |
| DK2147104T3 (en) | 2007-05-21 | 2015-12-14 | Danisco Us Inc | USING A ASPARAGINPROTEASE- (NSP24) SIGNAL SEQUENCE FOR heterologous protein EXPRESSION |
| US8324578B2 (en) | 2008-09-30 | 2012-12-04 | Apple Inc. | Hidden sensors in an electronic device |
| KR101410845B1 (ko) | 2009-09-10 | 2014-06-23 | 바이오콘 리미티드 | 새로운 프로리파제-보바인 트립시노겐 융합 단백질 |
| JP2012107935A (ja) * | 2010-11-16 | 2012-06-07 | Mitsubishi Chemicals Corp | Ｄｅｓｍｏｇｌｅｉｎ−２蛋白質による脳梗塞の検査方法 |
| RU2632651C2 (ru) | 2011-05-11 | 2017-10-06 | Чилдрен'С Медикал Сентер Корпорейшн | Модифицированный биотин-связывающий белок, слитые белки на его основе и их применение |
| EP3568697B1 (en) * | 2017-01-13 | 2022-06-29 | The Hospital for Sick Children | Method for diagnosis of arrhythmogenic right ventricular cardiomyopathy |
| CA3202364A1 (en) * | 2020-12-15 | 2022-06-23 | Arvada Therapeutics, Inc. | Dsg2 compositions and methods for the treatment of covid-19 |
-
2022
- 2022-11-02 MX MX2024005327A patent/MX2024005327A/es unknown
- 2022-11-02 JP JP2024525855A patent/JP2024540220A/ja active Pending
- 2022-11-02 CN CN202280073102.9A patent/CN118369351A/zh active Pending
- 2022-11-02 IL IL312219A patent/IL312219A/en unknown
- 2022-11-02 KR KR1020247018502A patent/KR20240110819A/ko active Pending
- 2022-11-02 EP EP22829631.5A patent/EP4426430A1/en active Pending
- 2022-11-02 AU AU2022382972A patent/AU2022382972A1/en active Pending
- 2022-11-02 AR ARP220103004A patent/AR127555A1/es unknown
- 2022-11-02 TW TW111141818A patent/TW202334190A/zh unknown
- 2022-11-02 CA CA3236070A patent/CA3236070A1/en active Pending
- 2022-11-02 WO PCT/US2022/079106 patent/WO2023081674A1/en not_active Ceased
-
2024
- 2024-05-01 US US18/652,115 patent/US20240279304A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12152060B2 (en) | Interleukin-2 variants and methods of uses thereof | |
| Ko et al. | An Fc variant with two mutations confers prolonged serum half-life and enhanced effector functions on IgG antibodies | |
| JP7462621B2 (ja) | 三重特異性抗ｃｄ３８、抗ｃｄ２８、および抗ｃｄ３結合タンパク質ならびにウイルス感染を処置するための使用方法 | |
| US9518132B2 (en) | Protein complexes for antigen binding and methods of use | |
| JP6850255B2 (ja) | 抗−ｃｄ４７抗体及びその使用 | |
| RU2015145719A (ru) | Модифицированные асимметричные антитела, связывающие fc-рецептор, и способы их применения | |
| BR112019016104A2 (pt) | composição farmacêutica de baixo ph compreendendo construtos de anticorpo que empregam células t | |
| JP2009523459A5 (enExample) | ||
| JP2016508153A5 (enExample) | ||
| CN107001468A (zh) | Cd3结合结构域 | |
| JP2022549172A5 (enExample) | ||
| JP2021518132A5 (enExample) | ||
| JPWO2017110980A1 (ja) | 増強された活性を有する抗体及びその改変方法 | |
| JP2023532129A5 (enExample) | ||
| TWI801336B (zh) | 重組靜脈內免疫球蛋白（ｒＩＶＩＧ）組合物及其生產方法和應用 | |
| JP2024504923A5 (enExample) | ||
| CA3134224A1 (en) | Composition for preventing or treating brain and nervous system disease | |
| JP2022540918A5 (enExample) | ||
| JP2024504777A5 (enExample) | ||
| JP2019506408A5 (enExample) | ||
| JP2024500250A5 (enExample) | ||
| JP2023551668A5 (enExample) | ||
| US20240279324A1 (en) | Multispecific antagonists | |
| JP2025517120A5 (enExample) | ||
| JP2024544531A (ja) | 位置４２９に変異を有するｆｃ領域成分を含む免疫療法タンパク質 |